<--- Back to Details
First PageDocument Content
Biosimilar / Biologic / Single-use bioreactor / Biopharmaceutical / Cell therapy / Bioprocess engineering / Microcarrier / Fed-batch / Monoclonal antibodies / Biotechnology / Biology / Clinical research
Date: 2014-06-03 02:48:21
Biosimilar
Biologic
Single-use bioreactor
Biopharmaceutical
Cell therapy
Bioprocess engineering
Microcarrier
Fed-batch
Monoclonal antibodies
Biotechnology
Biology
Clinical research

COVER CONFERENCE-AT-A-GLANCE SHORT COURSES TRAINING SEMINARS STREAM 1

Add to Reading List

Source URL: www.giievent.jp

Download Document from Source Website

File Size: 2,20 MB

Share Document on Facebook

Similar Documents

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v8Wa - View Document

Curtana Pharmaceuticals Selected to Present at Inaugural University Startups Demo Day in Washington, DC AUSTIN, TX – September 7, 2016 – Curtana Pharmaceuticals, a privately-held, preclinical stage biopharmaceutical

DocID: 1v7ko - View Document

INDUSTRY ISSUES What Is a Biopharmaceutical?

DocID: 1v72B - View Document

Beyond Operational Excellence through Digital Continuity Sustainable Health for Biopharmaceutical Manufacturing by Julie Fraser and Amy Rowell

DocID: 1v5W2 - View Document

TERMINOLOGY What is a Biopharmaceutical?

DocID: 1v5mX - View Document